📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

The Long-Term Safety, Public Health Impact, and Cost-Effectiveness of Routine Vaccination with a Recombinant, Live-Attenuated Dengue Vaccine (Dengvaxia): A Model Comparison Study. (2016)

First Author: Flasche S

Attributed to: MRC Centre for Outbreak Analysis and Modelling Renewal funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1371/journal.pmed.1002181

PubMed Identifier: 27898668

Publication URI: http://europepmc.org/abstract/MED/27898668

Type: Journal Article/Review

Volume: 13

Parent Publication: PLoS medicine

Issue: 11

ISSN: 1549-1277